₹ 25.30
-0.19 (-0.75%)
BSE
B
Beryl Drugs
₹ 25.30
BSE
Beryl Drugs EPS Summary
The latest quarterly EPS of Beryl Drugs as of Q1 Jun 2026 stands at ₹0.44. This is a 60.36% fall quarter on quarter and 1,000.00% growth same quarter last year. For the FY2026 the EPS of Beryl Drugs stands at ₹0.84. This is a 26.32% fall compared with FY2025.
Beryl Drugs EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

